StockLearn from Clustermicro · Stock Breakout ScannerStockLearn

Bayer CropScience (BAYERCROP)

Chemicals · NSE · end-of-day 2026-10-19

₹3,548.20

Day change

-2.49%

1-year

-29.8%

From 52-week high

-30.6%

Weinstein stage

Stage 4

Minervini template

0/8

Bayer CropScience closed at ₹3,548.20 on 2026-10-19, down 30% over the past year, 31% below its 52-week high. It meets 0 of 8 conditions of Minervini's trend template; Weinstein's stage analysis reads stage 4 - declining; on earnings, it passes 1 of 3 SEPA checks. Over the year its annualised volatility was about 21%, with a largest fall of 34% from a peak.

About Bayer CropScience

Bayer CropScience Limited develops crop protection products, seeds, biotechnology solutions, and digital farming technologies for agriculture. The company combines scientific research with precision farming tools to improve agricultural productivity. Innovation-led products strengthen long-term competitiveness. Growing food demand supports agricultural investment. Global research expertise remains a key advantage.

Price, RSI and MACD

6M1Y2Y3Y

Price · -26.9% over the period

RSI (14) · 39.2

MACD (12, 26, 9) · histogram +19.96

Price · -29.1% over the period

RSI (14) · 39.2

MACD (12, 26, 9) · histogram +19.96

Price · -46.6% over the period

RSI (14) · 39.2

MACD (12, 26, 9) · histogram +19.96

Price · -32.6% over the period

RSI (14) · 39.2

MACD (12, 26, 9) · histogram +19.96

Price: daily close adjusted for splits and bonuses, dashed line the 150-day moving average. MACD: green line, orange dashed signal, bars the histogram. Longer periods are drawn from every second or third session.

Fundamentals

Market cap	Sales (TTM)	Net profit (TTM)	P/E	EPS (TTM)	P/B	ROE	Beta
₹15,944 cr	₹5,595 cr	₹732 cr	21.8	162.90	5.38	24.7%	0.47

Quarterly results

Quarter	Sales ₹ cr	Net profit ₹ cr	EPS	EPS YoY	Sales YoY	Net margin
Jun 2026	1,835	322	71.56	+15.4%	-4.2%	17.5%
Mar 2026	1,101	162	36.07	+13.1%	+5.2%	14.7%
Dec 2025	1,106	96	21.29	—	—	8.6%
Sep 2025	1,553	153	33.98	—	—	9.8%
Jun 2025	1,915	279	62.01	—	—	14.6%
Mar 2025	1,046	143	31.88	—	—	13.7%

Standalone · EPS restated onto today's share count after splits and bonuses · net profit as filed.

Minervini SEPA — earnings checks 1 of 3 pass

Check	Result
Latest quarter EPS up 25%+ on a year ago	✗ Fail
EPS growth accelerating over 3 quarters	— Not assessable
Sales up 25%+, or sales growth accelerating	✗ Fail
Annual EPS up 25%+ in each of the last 2 years	— Not assessable
Net margin above the same quarter last year	✓ Pass

Investor methods

Method	Checks	Score	Verdict
Minervini	✗ Close above the 150- and 200-day averages ✗ 150-day above 200-day ✗ 200-day rising for a month ✗ 50-day above the 150- and 200-day ✗ Close above the 50-day ✗ At least 25% above the 52-week low · low 3,381.60 ✗ Within 25% of the 52-week high · high 5,113.20 ✗ RS percentile 70 or more · RS 15 Trend template - the gate, measured: a modest 21-day edge.	0/8	0 of 8
Weinstein	Stan Weinstein's stage analysis on the 30-week moving average.		Stage 4 - declining
CAN SLIM	✗ C latest quarter EPS up 25%+ — A annual EPS up 25%+ in each of the last 2 years · O'Neil asks 3; ~2 held ✗ N within 15% of the 52-week high · high 5,113.20 ✗ S more volume on up days than down days (50 sessions) · 0.29x ✗ L RS percentile 80 or more · RS 15 — I institutional sponsorship rising · shareholding not collected yet ✓ M market in an uptrend (40%+ of stocks above their 200-day) · breadth 45% William O'Neil's growth-leader checklist.	1/5	Weak
Darvas	✗ New 52-week high in the last 120 sessions Darvas needs a new 52-week high to start a box.	10/100	No box
Turtle	✗ Close above the prior 55-session high · 4,355.00 ✗ Close above the prior 20-session high · 3,899.10 ✗ Close below the prior 20-session low · 3,366.30 Donchian channel breakout - the Turtle traders' entry.		No signal
Graham	✗ Price at or below the Graham number · Graham number 1,554.76 ✗ P/E 15 or less · P/E 21.8 ✗ P/B 1.5 or less (or P/E x P/B 22.5 or less) · P/B 5.38 — Current ratio 2 or more — 10 years of positive earnings, 20 of dividends · history not held Benjamin Graham's defensive-investor tests.	44/100	Expensive

Each method's own rules applied to this stock - information, not a buy or sell signal. All were tested on 2024-26 data; only the Minervini trend template showed a consistent edge.

Chemicals sector — top 10 by 1-year return

Stock	1M %	3M %	6M %	1Y %	3Y %	5Y %	P/E	P/B	ROE %	ROCE %	ROA %	D/E	EV/EBITDA	₹ Cr	Sales TTM ₹ Cr	Profit TTM ₹ Cr	EPS	Beta
BAYERCROP this stock	-6.1	-16.7	-26.9	-29.4	-31.4	-31.9	21.8	5.38	24.7	—	—	—	—	15,944	5,595	732	162.9	0.47
BHAGERIA	+4.9	+66.0	+118.9	+103.3	+119.5	+20.6	22.2	2.57	8.0	10.1	—	0.17	17.2	1,533	1,003	68	15.8	0.95
INDOBORAX	-3.0	-4.8	+80.2	+97.5	+185.7	—	22.1	3.80	15.1	18.4	—	0.00	21.5	1,470	286	66	20.7	0.44
ANTELOPUS	-9.2	+16.4	+63.8	+92.3	—	—	26.6	5.38	15.9	21.4	—	0.00	21.0	3,525	359	133	37.8	-0.32
NGLFINE	+0.2	-7.9	+20.6	+82.7	+48.7	—	29.9	5.20	15.7	17.1	—	0.33	20.9	1,713	536	57	92.6	1.28
RAIN	+8.3	+5.7	+68.3	+77.6	+37.5	-7.8	14.0	0.94	0.6	8.2	—	1.35	5.8	7,537	18,464	667	16.0	1.42
APCOTEXIND	-6.3	+2.7	+44.8	+56.5	+9.9	+39.2	18.2	4.73	17.3	20.1	—	0.15	16.1	2,939	1,591	161	31.1	0.94
OCCLLTD	+23.5	+40.2	+93.8	+53.5	—	—	12.7	2.20	11.5	12.5	—	0.20	11.8	950	602	75	15.0	1.08
IGPL	+2.3	+31.2	+32.9	+35.8	+8.7	-32.7	21.2	1.30	0.2	3.1	—	0.27	17.4	1,733	2,073	82	26.5	1.13
KINGFA	+9.9	+26.8	+34.5	+35.4	+162.1	+542.2	32.7	6.20	17.4	23.4	—	0.00	30.9	8,680	2,684	266	195.9	0.52
VISHNU	-14.8	-3.8	+7.9	+31.1	+80.0	+339.6	27.6	3.88	14.3	16.3	—	0.49	17.6	4,144	1,696	150	22.3	0.71

A blank in a return column means the stock is younger than that window. P/B and ROE come from each company's own filings where held.

Chemicals stocks of a similar size

Tata Chemicals Chambal Fertilisers Paradeep Phosphates Sumitomo Chemical India Privi Speciality Chemicals Limited Anupam Rasayan India Limited Deepak Nitrite Pcbl

The live scanner - every stock ranked, filtered by method, stage and sector, with interactive charts - is in the StockLearn app. Open the StockLearn scanner →

Prices as of 2026-10-19, end of day, from NSE. Fundamentals from each company's own exchange filings (XBRL), EPS restated for splits and bonuses. Figures may be delayed and are for information only.

For research & education only — not investment advice. The methods, checks and verdicts are automated rules applied to public data, not buy/sell recommendations. StockLearn is an independent product of ClusterMicro Technologies, not affiliated with or endorsed by the NSE or any exchange. ClusterMicro Technologies is not a SEBI-registered investment adviser. Consult a SEBI-registered adviser before investing.

Terms · Privacy · Disclaimer · Refund · Contact